|
|
|
Volumn 18, Issue 16, 2004, Pages 38-39
|
|
Diagnostics + therapy = theranostics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CMD 193;
CYTOCHROME P450 2C19;
CYTOCHROME P450 2D6;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GEFITINIB;
GEMTUZUMAB OZOGAMICIN;
METHYLTRANSFERASE;
MONOCLONAL ANTIBODY;
RAPAMYCIN 2,2 BIS(HYDROXYMETHYL)PROPIONATE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
COLON TUMOR;
COST BENEFIT ANALYSIS;
DIAGNOSTIC TEST;
DISEASE MARKER;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
GENE MUTATION;
GENOTYPE;
HEPATITIS;
HUMAN;
KIDNEY CANCER;
LEUKEMIA;
LUNG CANCER;
ONCOGENE NEU;
PATIENT CARE;
PRACTICE GUIDELINE;
PROTEIN EXPRESSION;
RECURRENT DISEASE;
SHORT SURVEY;
TREATMENT PLANNING;
|
|
EID: 4644241347
PISSN: 08903670
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (99)
|
|
References (0)
|
